Top of page
References
- Yaman O, Tokatli Z, Akand M, Elhan AH, Anafarta K. Characteristics of sildenafil erections in healthy young men. Asian J Androl 2005; 7: 395–8. | Article | PubMed | ChemPort |
- Son H, Park K, Kim SW, Paick JS. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Asian J Androl 2004; 6: 117–20. | PubMed | ISI | ChemPort |
- Gooren LJ, Saad F. Recent insights into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 2006; 8: 3–9. | Article | PubMed | ChemPort |
- Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta analysis. Arch Intern Med 2002; 162: 1349–60. | Article | PubMed | ISI | ChemPort |
- Moore RA, Edwards JE, McQuay HJ. Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports. BMC Urol 2002; 2–6.
- Chockalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T, et al. Efficacy and optimal dose of sildenafil in primary pulmonary hypertension. Int J Cardiol 2005; 99: 91–5. | Article | PubMed | ISI |


